Optimizing Care for HCM Patients: Evidence-Based, Pathology-Targeted Management for All

Mar 29, 2025

- Mar 28, 2026

1.0

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs)

This course is available for logged in users only. Please login or register to take the course.

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosi...

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis